The US Food and Drug Administration said that it had approved Nabriva Therapeutics’ antibiotic Xenleta for treating patients with community-acquired pneumonia.
Date:2019-08-22 Views:511
The US Food and Drug Administration said that it had approved Nabriva Therapeutics’ antibiotic Xenleta for treating patients with community-acquired pneumonia.
